AMYRIAD THERAPEUTICS Trademark

Trademark Overview


On Wednesday, November 3, 2021, a trademark application was filed for AMYRIAD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AMYRIAD THERAPEUTICS trademark a serial number of 97107538. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, November 15, 2024. This trademark is owned by AmyriAD Therapeutics B.V.. The AMYRIAD THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins

Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing

General Information


Serial Number97107538
Word MarkAMYRIAD THERAPEUTICS
Filing DateWednesday, November 3, 2021
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, November 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmyriAD Therapeutics B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLos Angeles, CA 90071

Trademark Events


Event DateEvent Description
Saturday, November 6, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 12, 2022ASSIGNED TO EXAMINER
Friday, August 19, 2022NON-FINAL ACTION WRITTEN
Friday, August 19, 2022NON-FINAL ACTION E-MAILED
Friday, August 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023SUSPENSION LETTER WRITTEN
Monday, February 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, February 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 12, 2024ASSIGNED TO EXAMINER
Monday, April 15, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, May 16, 2024NON-FINAL ACTION E-MAILED
Thursday, May 16, 2024NON-FINAL ACTION WRITTEN
Thursday, May 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, November 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED